Photo taken from
Udhayvir Grewal/X
Jul 5, 2025, 16:24
Udhayvir Grewal: Key Challenges With First-Generation Agents and What’s Ahead for MUC1
Udhayvir Grewal, Resident Physician at Ochsner LSU Health Shreveport Academy Medical Centre, shared a post on X:
“Excited to share our new review in npj Journals Precision Oncology: ‘Mucin-1: A Promising Pan-Cancer Therapeutic Target’
We discuss:
- How aberrant MUC1 expression and glycosylation drive oncogenesis in solid and hematologic cancers
- The pipeline of MUC1-targeted therapies — including vaccines, CAR-T cells, ADCs, radiopharmaceuticals, and bispecifics
- Key challenges with first-generation agents and what’s ahead for MUC1.
Thank you Dr. Razelle Kurzrock for your mentorship and guidance in helping bring this work to life.”
Title: Mucin-1: a promising pan-cancer therapeutic target
Authors: Udhayvir Singh Grewal and Razelle Kurzrock
You can read the Full Article on npj Precision Oncology
More posts featuring Udhayvir Grewal.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 5, 2025, 20:31
Jul 5, 2025, 20:15
Jul 5, 2025, 20:00
Jul 5, 2025, 19:18
Jul 5, 2025, 18:52
Jul 5, 2025, 18:38